The Center joined with Avaxia Biologics, a development stage company focusing on oral antibody therapeutics that act locally within the gastrointestinal tract, to host a ribbon cutting ceremony for the company’s new office and lab space in Lexington. The company received $375,000 in early-stage loan financing through the Center’s Accelerator Program in 2010.
Olaris is a precision diagnostics company that is on a mission to revolutionize how diseases are diagnosed and treated. By leveraging their CEREBRO platform (Comprehensive Early Responsive Evaluation of Biomarkers Related to Outcomes), which combines metabolomics and machine learning, they are able to harness the power of the body’s own communication system to discover and develop their pipeline of myOLARIS precision diagnostics.
